APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etoposide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Etoposide Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchEtoposide Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Etoposide Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Etoposide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etoposide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Etoposide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Etoposide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Etoposide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Etoposide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Etoposide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Etoposide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Etoposide market include Teva Pharmaceutical, Qilu Antibiotics, Mylan, China Resources Double Crane Pharmaceutical, Shyndec Pharmaceutical, Nippon Kayaku, KPC Pharmaceuticals, Gansu Fuzheng and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Etoposide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Etoposide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Etoposide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Etoposide market size, projected growth trends, production technologies, key applications, and end-use industries.

Etoposide Segment by Company

Teva Pharmaceutical

Qilu Antibiotics

Mylan

China Resources Double Crane Pharmaceutical

Shyndec Pharmaceutical

Nippon Kayaku

KPC Pharmaceuticals

Gansu Fuzheng

Accord Healthcare

Etoposide Segment by Type

Etoposide for Injection

Etoposide for Oral Use

Etoposide Segment by Application

Small Cell Lung Cancer

Testicular Cancer

Etoposide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Etoposide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Etoposide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Etoposide significant trends, drivers, influence factors in global and regions.

6. To analyze Etoposide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etoposide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etoposide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etoposide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Etoposide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Etoposide industry.

Chapter 3: Detailed analysis of Etoposide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Etoposide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Etoposide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Etoposide Industry Trends Table 2. Etoposide Industry Drivers Table 3. Etoposide Industry Opportunities and Challenges Table 4. Etoposide Industry Restraints Table 5. Global Etoposide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Etoposide Revenue Share by Company (2021-2026) Table 7. Global Etoposide Sales Volume by Company (units) & (2021-2026) Table 8. Global Etoposide Sales Volume Share by Company (2021-2026) Table 9. Global Etoposide Average Price (k US$/unit) of Company (2021-2026) Table 10. Global Etoposide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Etoposide Key Company Manufacturing Base & Headquarters Table 12. Global Etoposide Company, Product Type & Application Table 13. Global Etoposide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Etoposide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Etoposide for Injection Table 18. Significant Companies of Etoposide for Oral Use Table 19. Global Etoposide Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 20. Global Etoposide Sales Volume by Type (2021-2026) & (units) Table 21. Global Etoposide Sales Volume by Type (2027-2032) & (units) Table 22. Global Etoposide Sales Volume Share by Type (2021-2026) Table 23. Global Etoposide Sales Volume Share by Type (2027-2032) Table 24. Global Etoposide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Etoposide Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Etoposide Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Etoposide Sales Value Share by Type (2021-2026) Table 28. Global Etoposide Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Small Cell Lung Cancer Table 30. Significant Companies of Testicular Cancer Table 31. Global Etoposide Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 32. Global Etoposide Sales Volume by Application (2021-2026) & (units) Table 33. Global Etoposide Sales Volume by Application (2027-2032) & (units) Table 34. Global Etoposide Sales Volume Share by Application (2021-2026) Table 35. Global Etoposide Sales Volume Share by Application (2027-2032) Table 36. Global Etoposide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Etoposide Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Etoposide Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Etoposide Sales Value Share by Application (2021-2026) Table 40. Global Etoposide Sales Value Share by Application (2027-2032) Table 41. Global Etoposide Sales by Region: 2021 VS 2025 VS 2032 (units) Table 42. Global Etoposide Sales by Region (2021-2026) & (units) Table 43. Global Etoposide Sales Market Share by Region (2021-2026) Table 44. Global Etoposide Sales by Region (2027-2032) & (units) Table 45. Global Etoposide Sales Market Share by Region (2027-2032) Table 46. Global Etoposide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Etoposide Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Etoposide Sales Value Share by Region (2021-2026) Table 49. Global Etoposide Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Etoposide Sales Value Share by Region (2027-2032) Table 51. Global Etoposide Market Average Price (k US$/unit) by Region (2021-2026) Table 52. Global Etoposide Market Average Price (k US$/unit) by Region (2027-2032) Table 53. Global Etoposide Sales by Country: 2021 VS 2025 VS 2032 (units) Table 54. Global Etoposide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Etoposide Sales by Country (2021-2026) & (units) Table 56. Global Etoposide Sales Market Share by Country (2021-2026) Table 57. Global Etoposide Sales by Country (2027-2032) & (units) Table 58. Global Etoposide Sales Market Share by Country (2027-2032) Table 59. Global Etoposide Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Etoposide Sales Value Market Share by Country (2021-2026) Table 61. Global Etoposide Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Etoposide Sales Value Market Share by Country (2027-2032) Table 63. Teva Pharmaceutical Company Information Table 64. Teva Pharmaceutical Business Overview Table 65. Teva Pharmaceutical Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Etoposide Product Portfolio Table 67. Teva Pharmaceutical Recent Development Table 68. Qilu Antibiotics Company Information Table 69. Qilu Antibiotics Business Overview Table 70. Qilu Antibiotics Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 71. Qilu Antibiotics Etoposide Product Portfolio Table 72. Qilu Antibiotics Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 76. Mylan Etoposide Product Portfolio Table 77. Mylan Recent Development Table 78. China Resources Double Crane Pharmaceutical Company Information Table 79. China Resources Double Crane Pharmaceutical Business Overview Table 80. China Resources Double Crane Pharmaceutical Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 81. China Resources Double Crane Pharmaceutical Etoposide Product Portfolio Table 82. China Resources Double Crane Pharmaceutical Recent Development Table 83. Shyndec Pharmaceutical Company Information Table 84. Shyndec Pharmaceutical Business Overview Table 85. Shyndec Pharmaceutical Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 86. Shyndec Pharmaceutical Etoposide Product Portfolio Table 87. Shyndec Pharmaceutical Recent Development Table 88. Nippon Kayaku Company Information Table 89. Nippon Kayaku Business Overview Table 90. Nippon Kayaku Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 91. Nippon Kayaku Etoposide Product Portfolio Table 92. Nippon Kayaku Recent Development Table 93. KPC Pharmaceuticals Company Information Table 94. KPC Pharmaceuticals Business Overview Table 95. KPC Pharmaceuticals Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 96. KPC Pharmaceuticals Etoposide Product Portfolio Table 97. KPC Pharmaceuticals Recent Development Table 98. Gansu Fuzheng Company Information Table 99. Gansu Fuzheng Business Overview Table 100. Gansu Fuzheng Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 101. Gansu Fuzheng Etoposide Product Portfolio Table 102. Gansu Fuzheng Recent Development Table 103. Accord Healthcare Company Information Table 104. Accord Healthcare Business Overview Table 105. Accord Healthcare Etoposide Sales (units), Value (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 106. Accord Healthcare Etoposide Product Portfolio Table 107. Accord Healthcare Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Etoposide Distributors List Table 111. Etoposide Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Etoposide Product Image Figure 2. Global Etoposide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etoposide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Etoposide Sales (2021-2032) & (units) Figure 5. Global Etoposide Sales Average Price (k US$/unit) & (2021-2032) Figure 6. Global Etoposide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Etoposide for Injection Image Figure 10. Etoposide for Oral Use Image Figure 11. Global Etoposide Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 12. Global Etoposide Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Etoposide Sales Volume Share by Type (2021-2032) Figure 14. Global Etoposide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Etoposide Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Etoposide Sales Value Share by Type (2021-2032) Figure 17. Small Cell Lung Cancer Image Figure 18. Testicular Cancer Image Figure 19. Global Etoposide Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 20. Global Etoposide Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Etoposide Sales Volume Share by Application (2021-2032) Figure 22. Global Etoposide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Etoposide Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Etoposide Sales Value Share by Application (2021-2032) Figure 25. Global Etoposide Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 26. Global Etoposide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Etoposide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Etoposide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Etoposide Sales Value (2021-2032) & (US$ Million) Figure 30. North America Etoposide Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Etoposide Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Etoposide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Etoposide Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Etoposide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Etoposide Sales Value (2021-2032) & (US$ Million) Figure 36. South America Etoposide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Etoposide Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Etoposide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Etoposide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Etoposide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Etoposide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Etoposide Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Etoposide Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Etoposide for Injection
  • Etoposide for Oral Use
Applications
  • Small Cell Lung Cancer
  • Testicular Cancer
Companies covered
  • Teva Pharmaceutical
  • Qilu Antibiotics
  • Mylan
  • China Resources Double Crane Pharmaceutical
  • Shyndec Pharmaceutical
  • Nippon Kayaku
  • KPC Pharmaceuticals
  • Gansu Fuzheng
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Etoposide Sales Value (2021-2032)
  4. 1.2.2 Global Etoposide Sales Volume (2021-2032)
  5. 1.2.3 Global Etoposide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Etoposide Market Dynamics
  1. 2.1 Etoposide Industry Trends
  2. 2.2 Etoposide Industry Drivers
  3. 2.3 Etoposide Industry Opportunities and Challenges
  4. 2.4 Etoposide Industry Restraints
3 Etoposide Market by Company
  1. 3.1 Global Etoposide Company Revenue Ranking in 2025
  2. 3.2 Global Etoposide Revenue by Company (2021-2026)
  3. 3.3 Global Etoposide Sales Volume by Company (2021-2026)
  4. 3.4 Global Etoposide Average Price by Company (2021-2026)
  5. 3.5 Global Etoposide Company Ranking (2024-2026)
  6. 3.6 Global Etoposide Company Manufacturing Base and Headquarters
  7. 3.7 Global Etoposide Company Product Type and Application
  8. 3.8 Global Etoposide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Etoposide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Etoposide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Etoposide Market by Type
  1. 4.1 Etoposide Type Introduction
  2. 4.1.1 Etoposide for Injection
  3. 4.1.2 Etoposide for Oral Use
  4. 4.2 Global Etoposide Sales Volume by Type
  5. 4.2.1 Global Etoposide Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Etoposide Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Etoposide Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Etoposide Sales Value by Type
  9. 4.3.1 Global Etoposide Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Etoposide Sales Value by Type (2021-2032)
  11. 4.3.3 Global Etoposide Sales Value Share by Type (2021-2032)
5 Etoposide Market by Application
  1. 5.1 Etoposide Application Introduction
  2. 5.1.1 Small Cell Lung Cancer
  3. 5.1.2 Testicular Cancer
  4. 5.2 Global Etoposide Sales Volume by Application
  5. 5.2.1 Global Etoposide Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Etoposide Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Etoposide Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Etoposide Sales Value by Application
  9. 5.3.1 Global Etoposide Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Etoposide Sales Value by Application (2021-2032)
  11. 5.3.3 Global Etoposide Sales Value Share by Application (2021-2032)
6 Etoposide Regional Sales and Value Analysis
  1. 6.1 Global Etoposide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Etoposide Sales by Region (2021-2032)
  3. 6.2.1 Global Etoposide Sales by Region: 2021-2026
  4. 6.2.2 Global Etoposide Sales by Region (2027-2032)
  5. 6.3 Global Etoposide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Etoposide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Etoposide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Etoposide Sales Value by Region (2027-2032)
  9. 6.5 Global Etoposide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Etoposide Sales Value (2021-2032)
  12. 6.6.2 North America Etoposide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Etoposide Sales Value (2021-2032)
  15. 6.7.2 Europe Etoposide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Etoposide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Etoposide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Etoposide Sales Value (2021-2032)
  21. 6.9.2 South America Etoposide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Etoposide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Etoposide Sales Value Share by Country, 2025 VS 2032
7 Etoposide Country-level Sales and Value Analysis
  1. 7.1 Global Etoposide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Etoposide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Etoposide Sales by Country (2021-2032)
  4. 7.3.1 Global Etoposide Sales by Country (2021-2026)
  5. 7.3.2 Global Etoposide Sales by Country (2027-2032)
  6. 7.4 Global Etoposide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Etoposide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Etoposide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Etoposide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Etoposide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Etoposide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Etoposide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Etoposide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Etoposide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Etoposide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Etoposide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Etoposide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Etoposide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Etoposide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Etoposide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Etoposide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Etoposide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Etoposide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Etoposide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Etoposide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Etoposide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Etoposide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Etoposide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Etoposide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Etoposide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Etoposide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Etoposide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Etoposide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Etoposide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Etoposide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Etoposide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Etoposide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Etoposide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Etoposide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Etoposide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Etoposide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Etoposide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Etoposide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Etoposide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Etoposide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Etoposide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Etoposide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Etoposide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Etoposide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Etoposide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Etoposide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Etoposide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Etoposide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Etoposide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Etoposide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Etoposide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Etoposide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Etoposide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Etoposide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Etoposide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Etoposide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Etoposide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Etoposide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Etoposide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Etoposide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Etoposide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Etoposide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Etoposide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Etoposide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Etoposide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Etoposide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Etoposide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Etoposide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Etoposide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Etoposide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Etoposide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Etoposide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Etoposide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Etoposide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Etoposide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Etoposide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Etoposide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Etoposide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Etoposide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Etoposide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Etoposide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Etoposide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Etoposide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Etoposide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Etoposide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Etoposide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Etoposide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Etoposide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Etoposide Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Qilu Antibiotics
  8. 8.2.1 Qilu Antibiotics Company Information
  9. 8.2.2 Qilu Antibiotics Business Overview
  10. 8.2.3 Qilu Antibiotics Etoposide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Antibiotics Etoposide Product Portfolio
  12. 8.2.5 Qilu Antibiotics Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Etoposide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Etoposide Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 China Resources Double Crane Pharmaceutical
  20. 8.4.1 China Resources Double Crane Pharmaceutical Company Information
  21. 8.4.2 China Resources Double Crane Pharmaceutical Business Overview
  22. 8.4.3 China Resources Double Crane Pharmaceutical Etoposide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 China Resources Double Crane Pharmaceutical Etoposide Product Portfolio
  24. 8.4.5 China Resources Double Crane Pharmaceutical Recent Developments
  25. 8.5 Shyndec Pharmaceutical
  26. 8.5.1 Shyndec Pharmaceutical Company Information
  27. 8.5.2 Shyndec Pharmaceutical Business Overview
  28. 8.5.3 Shyndec Pharmaceutical Etoposide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shyndec Pharmaceutical Etoposide Product Portfolio
  30. 8.5.5 Shyndec Pharmaceutical Recent Developments
  31. 8.6 Nippon Kayaku
  32. 8.6.1 Nippon Kayaku Company Information
  33. 8.6.2 Nippon Kayaku Business Overview
  34. 8.6.3 Nippon Kayaku Etoposide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nippon Kayaku Etoposide Product Portfolio
  36. 8.6.5 Nippon Kayaku Recent Developments
  37. 8.7 KPC Pharmaceuticals
  38. 8.7.1 KPC Pharmaceuticals Company Information
  39. 8.7.2 KPC Pharmaceuticals Business Overview
  40. 8.7.3 KPC Pharmaceuticals Etoposide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 KPC Pharmaceuticals Etoposide Product Portfolio
  42. 8.7.5 KPC Pharmaceuticals Recent Developments
  43. 8.8 Gansu Fuzheng
  44. 8.8.1 Gansu Fuzheng Company Information
  45. 8.8.2 Gansu Fuzheng Business Overview
  46. 8.8.3 Gansu Fuzheng Etoposide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gansu Fuzheng Etoposide Product Portfolio
  48. 8.8.5 Gansu Fuzheng Recent Developments
  49. 8.9 Accord Healthcare
  50. 8.9.1 Accord Healthcare Company Information
  51. 8.9.2 Accord Healthcare Business Overview
  52. 8.9.3 Accord Healthcare Etoposide Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Accord Healthcare Etoposide Product Portfolio
  54. 8.9.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Etoposide Value Chain Analysis
  2. 9.1.1 Etoposide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Etoposide Sales Mode & Process
  6. 9.2 Etoposide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Etoposide Distributors
  9. 9.2.3 Etoposide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst